Institution

Nome:
Merck Sharp & Dohme
URL:
http://www.msd.pt/Paginas/home.aspx
Articles 6:

Cost-Effectiveness Analysis of Boceprevir for the Treatment of Chronic Hepatitis C Virus Genotype 1 Infection in Portugal
Elamin H. Elbasha, Jagpreet Chhatwal, Shannon A. Ferrante, Antoine C. El Khoury, Pedro A. Laires
Applied Health Economics And Health Policy, vol. 11, 2013, p. 65-78.

Cost-Effectiveness Analysis of Boceprevir for the Treatment of Chronic Hepatitis C Virus Genotype 1 Infection in Portugal
Elamin H. Elbasha, Jagpreet Chhatwal, Shannon A. Ferrante, Antoine C. El Khoury, Pedro A. Laires
Applied Health Economics And Health Policy, vol. 11, 2013, p. 65-78.

Cost-Effectiveness Analysis of Boceprevir for the Treatment of Chronic Hepatitis C Virus Genotype 1 Infection in Portugal
Elamin H. Elbasha, Jagpreet Chhatwal, Shannon A. Ferrante, Antoine C. El Khoury, Pedro A. Laires
Applied Health Economics And Health Policy, vol. 11, 2013, p. 65-78.

Patients` Access to Biologics in Rheumatoid Arthritis: A Comparison between Portugal and Other European Countries
Pedro A. Laires, F. Exposto, Rui Mesquita, Ana P. Martins, Luís Cunha-Miranda, João Eurico Fonseca
European Journal Of Health Economics, vol. 14, 2013, p. 875-885.

Patients` Access to Biologics in Rheumatoid Arthritis: A Comparison between Portugal and Other European Countries
Pedro A. Laires, F. Exposto, Rui Mesquita, Ana P. Martins, Luís Cunha-Miranda, João Eurico Fonseca
European Journal Of Health Economics, vol. 14, 2013, p. 875-885.

Patients` Access to Biologics in Rheumatoid Arthritis: A Comparison between Portugal and Other European Countries
Pedro A. Laires, F. Exposto, Rui Mesquita, Ana P. Martins, Luís Cunha-Miranda, João Eurico Fonseca
European Journal Of Health Economics, vol. 14, 2013, p. 875-885.

Back